High-Dose Therapy Treatment in Patients With Follicular Lymphoma
Condition(s):Follicular LymphomaLast Updated:October 24, 2008Completed
Hide Studies Not Open or Pending
Condition(s):Follicular LymphomaLast Updated:October 24, 2008Completed
Condition(s):Rheumatoid ArthritisLast Updated:August 3, 2018Completed
Condition(s):Hodgkin LymphomaLast Updated:September 28, 2023Recruiting
Condition(s):COPD ExacerbationLast Updated:November 29, 2023Recruiting
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:October 6, 2023Completed
Condition(s):Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes; Non Hodgkin Lymphoma; Hodgkin Lymphoma; Multiple Myeloma; Chronic Myelogenous Leukemia; MyelofibrosisLast Updated:September 28, 2023Recruiting
Condition(s):Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic SyndromeLast Updated:May 18, 2021Completed
Condition(s):Prostate CancerLast Updated:January 5, 2021Not yet recruiting
Condition(s):IgA Nephropathy; Proteinuria in Nephrotic Range; Immunosuppressive TreatmentLast Updated:December 6, 2023Recruiting
Condition(s):Transplant; Failure, Kidney; EBVLast Updated:February 8, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.